Controversies in psychiatry
- PMID: 30581283
- PMCID: PMC6296394
- DOI: 10.31887/DCNS.2018.20.3/fthibaut
Controversies in psychiatry
Abstract
Neuroimaging and recent genetics discoveries have raised many questions regarding the current diagnostic criteria of psychiatric diseases and the current classifications used, which are still based on subjective clinical assessment. Despite high-quality research in brain neuroscience and evidence-based guidelines in many psychiatric diseases, some therapeutic issues are still a matter of debate. These controversial issues will be discussed in this 20th anniversary issue.
Keywords: biomarker; controversy; genetics; precision medicine; psychiatry.
References
-
- Giegling I., Hosak L., Mössner R., et al. Genetics of schizophrenia: A consensus paper of the WFSBP Task Force on Genetics. World J Biol Psychiatry. 2017;18(7):492–505. - PubMed
-
- Fabbri C., Hosak L., Mössner R., et al. Consensus paper of the WFSBP Task Force on Genetics: Genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant response. World J Biol Psychiatry. 2017;18(1):5–28. - PubMed
-
- Hashimoto E., Riederer PF., Hesselbrock VM., et al. Consensus paper of the WFSBP task force on biological markers: biological markers for alcoholism. World J Biol Psychiatry. 2013;14(8):549–564. - PubMed
-
- Lewczuk P., Riederer P., O'Bryant SE., et al. Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry. World J Biol Psychiatry. 2018;19(4):244–328. - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources